Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction

Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator

Karl-Ludwig Neuhaus, Werner Feuerer, Susanne Jeep-Tebbe et al. · Journal of the American College of Cardiology · 1989 · 299 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.

Herman K. Gold, Robert C. Leinbach, Haroutioun Garabedian et al. · Circulation · 1986 · 295 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study (TAPS)

K. L. Neuhaus, Ulrich Tebbe, Albrecht Vogt et al. · Journal of the American College of Cardiology · 1992 · 233 citations

Medicine, Cardiology, Pharmacology +12

Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator

Hiltrud S. Mueller, Anupama Rao, Sandra Forman · Journal of the American College of Cardiology · 1987 · 232 citations

Medicine, Cardiology, Clinical Cardiology +13

Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Urokinase in Acute Myocardial Infarction: Results of the German Activator Urokinase Study (GAUS)

Karl-Ludwig Neuhaus, Ulrich Tebbe, Martin Gottwik et al. · Journal of the American College of Cardiology · 1988 · 214 citations

Medicine, Cardiology, Internal Medicine +16